INFUSYSTEM HOLDINGS INC
INFUNYSE AMERICANTrading Snapshot
- Day Range
- $12.92 β $13.09
- 52-Week Range
- $7.29 β $13.20
- Volume
- $2.43B
- Avg Volume
- $2.82B
- Shares Outstanding
- 20.2M
- Next Earnings
- Dec 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $143M
- Last Q Revenue
- $37M
- P/E Ratio
- 29.6
- P/S Ratio
- 1.8x
- EPS (TTM)
- $0.41
- Dividend Yield
- β
- Dilution (1yr)
- β3.0%
Why Investors Own INFU
- βHigh-growth profile β revenue up +12.2% YoY with expanding US Equity exposure.
- βHealthy economics β 58% gross margin and 24% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
INFUSYSTEM HOLDINGS INC
INFUAbout INFUSYSTEM HOLDINGS INC
InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates

InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript
InfuSystem Holdings, Inc. (INFU) Discusses Business Overview and Growth Strategy with Focus on Patient-First Approach Transcript

Guardant Health (NASDAQ:GH) versus InfuSystem (NYSE:INFU) Critical Review
Guardant Health (NASDAQ: GH - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of

InfuSystem to Host Investor Webcast on September 24, 2026
ROCHESTER HILLS, Mich.--(BUSINESS WIRE)--InfuSystem to Host Investor Webcast on SeptemberΒ 24, 2026.

InfuSystem (NYSE:INFU) & Exagen (NASDAQ:XGN) Head to Head Contrast
Exagen (NASDAQ: XGN - Get Free Report) and InfuSystem (NYSE: INFU - Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of

BlackRock Inc. Takes Position in InfuSystem Holdings, Inc. $INFU
BlackRock Inc. bought a new position in shares of InfuSystem Holdings, Inc. (NYSE: INFU) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund

InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript
InfuSystem Holdings, Inc. (INFU) Q2 2026 Earnings Call Transcript